Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Endocrinological Investigation
Published in: Journal of Endocrinological Investigation 2/2005

01-02-2005 | Case Report

Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene

Authors: G. P. Bernini, MD, A. Moretti, M. Mannelli, T. Ercolino, M. Bardini, D. Caramella, C. Taurino, A. Salvetti

Published in: Journal of Endocrinological Investigation | Issue 2/2005

Login to get access
Metadata
Title
Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene
Authors
G. P. Bernini, MD
A. Moretti
M. Mannelli
T. Ercolino
M. Bardini
D. Caramella
C. Taurino
A. Salvetti
Publication date
01-02-2005
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 2/2005
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/BF03345345

Other articles of this Issue 2/2005

Journal of Endocrinological Investigation 2/2005 Go to the issue

Case Report

Teratogenicity with angiotensin II receptor antagonists in pregnancy

Announcement

Société Française d’Endocrinologie

Original Article

The IGF-I/IGFBP-3 system in gingival crevicular fluid and dependence on application of fixed force

Case Report

Intense 18-fluorodeoxyglucose uptake by the thymus on PET scan does not necessarily herald recurrence of thyroid carcinoma

Original Article

Effects of chronic retinoid administration on pituitary function

Original Article

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits